The National Cancer Patient Experience Survey 2019 is the ninth iteration of the survey, having ran annually since 2010. The survey is an important part of the national NHS Cancer Programme, which places patient experience on a par with clinical effectiveness and safety as a key strategic priority. It has been designed to monitor national progress on cancer care, to drive local quality improvements, to assist commissioners and providers of cancer care and to inform the work of the various charities and stakeholder groups supporting cancer patients.
The survey will comply with all aspects of the General Data Protection Regulation and the 2018 Data Protection Act. The 2019 iteration has received Section 251 approval from the Confidentiality Advisory Group. This means all participating trusts have been given the clearance to transfer data to Picker for the purpose of the 2019 National Cancer Patient Experience Survey.
The survey was overseen by a national Cancer Patient Experience Advisory Group. This Advisory Group set the principles and objectives of the survey programme and guided questionnaire development. The survey is commissioned and managed by NHS England. The implementation, analyses and reporting will be completed by Picker.